Aphena Pharma Solutions Inc., a contract packager, repackager, and manufacturer for the pharmaceutical, OTC, dietary supplements, animal health, health and beauty, consumer health, and medical device markets, has acquired 14 OTC products from G&W Laboratories.
The company reports in a press release that the acquisition is part of its strategy "to expand its existing and future customers' access to the growing private-label marketplace by purchasing both small- and large-scale private-label offerings."
As the entire Western Hemisphere approaches winter, flu season comes along with it. In the United States, National Influenza Vaccination Week (December 2-8, 2012) promotes awareness of getting flu shots and vaccines. It is important to build up our immune systems during this time. Antibiotics aid the immune system by attacking and killing infectious strains present in the human body. However, antibiotic treatments are engineered to attack contagions across a broad spectrum, thus killing all kinds of bacteria, whether they are beneficial to the body or not.
The Perrigo Company today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDA) to market over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor).